Pine Labs

Finance - Others
₹162.28
-0.48%
Prev close ₹163.07
Get AI-Powered Analysis for Pine Labs Free Analysis → FREE View live price, charts & full analysis for Pine Labs →

Pine Labs Share Price Chart

Pine Labs last traded at ₹162.28 (2026-10-13). Over the past month the stock moved -6.3%, three months the stock moved +17.6%. Its closing range over 52 weeks is ₹137.94 – ₹250.89, with the latest close 35.3% below the high.

Closing prices up to 2026-10-13.

About Pine Labs

Incorporated in 1998, Pine Labs is a leading Indian merchant commerce platform that provides point-of-sale (POS) solutions, payment processing, and merchant financing services.[1]

Business Profile[1] Pine Labs is a technology-first company focused on digitizing commerce in India and select global markets like Malaysia, Singapore, UAE, Australia, the US, and Africa. Their core business is providing digital payment and issuing solutions for merchants, consumer brands, enterprises, and financial institutions. Its customer base spans across department stores, supermarkets, retail chains, restaurants, grocery outlets, consumer electronics, healthcare, travel, hospitality, and a growing roster of banks and new-age technology firms

Fundamentals

Market Cap₹20398.64 Cr
52W High₹283.70
52W Low₹134.75
P/E Ratio160.59
P/B Ratio3.45
EPS₹1.10
Dividend Yield0%
ROE (3yr)-3%
Sales Growth (3yr)19%
Profit Growth (3yr)36%

Quarterly Results

In the latest quarter (Jun 2026), Pine Labs reported sales of ₹737.00 crore (+19.6%) and net profit of ₹20.00 crore (+300.0%), compared with the same quarter last year.

Pine Labs quarterly results (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Jun 2026737.0095.0013.0020.000.17
Mar 2026701.00106.0015.0059.000.52
Dec 2025744.00132.0018.0042.000.37
Sep 2025650.0075.0012.006.000.13
Jun 2025616.0045.007.005.000.11
Mar 2025599.0057.009.00-29.00-0.34
Dec 2024602.0077.0013.00-57.00-0.67
Sep 2024552.0032.006.00-32.00-0.38
Year-on-year change vs the same quarter last year
Sep 2025Dec 2025Mar 2026Jun 2026
Sales growth+17.8%+23.6%+17.0%+19.6%
Operating profit growth+134.4%+71.4%+86.0%+111.1%
Net profit growth–––+300.0%
EPS growth–––+54.5%
OPM %12.0%18.0%15.0%13.0%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

Annual Financials

In the latest year (Mar 2026), Pine Labs reported sales of ₹2,711.00 crore (+19.2%) and net profit of ₹113.00 crore, compared with the previous year.

Pine Labs annual profit & loss (₹ crore)
PeriodSalesOperating profitOPM %Net profitEPS (₹)
Mar 20262,711358.0013.00113.000.98
Mar 20252,274218.0010.00-145.00-1.73
Mar 20241,770-25.00-1.00-342.00-4.07
Mar 20231,281151.0012.00-56.00-4.02
Mar 2022932.00112.0012.00-23.00-1.67
Mar 2021670.00110.0016.00-56.00-4.34
Mar 2020848.0087.0010.00-47.00-3.95
Year-on-year change vs the previous year
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales growth-21.0%+39.1%+37.4%+38.2%+28.5%+19.2%
Operating profit growth+26.4%+1.8%+34.8%-116.6%–+64.2%
Net profit growth––––––
EPS growth––––––
OPM %16.0%12.0%12.0%-1.0%10.0%13.0%

Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.

AI Analysis

Recommendation: Sell

Pine Labs is in severe distress, down 14.4% today and 43.4% from its 52-week high of ₹283.7, with the stock now trading near its 52-week low of ₹151.15 amid IPO lock-in expiry selling pressure. While Q3 FY26 (Dec 2025) shows recovery with 18% OPM and ₹0.37 EPS, the annual FY25 result reveals structural profitability collapse (−₹145 Cr net loss, OPM 10%, ROE −3.9%, ROCE 0%), indicating the company has not yet stabilized earnings despite revenue growth to ₹2,274 Cr. The critical near-term risk is sustained lock-in seller supply overshadowing operational recovery.

Key Strengths:
  • Q3 FY26 operating margin recovery to 18% and EPS of ₹0.37 signals operational stabilization after FY25 structural losses, with sequential revenue growth (Dec ₹744 Cr vs Jun ₹616 Cr) demonstrating demand traction.
  • Market cap of ₹22,448 Cr with 28.8% large-cap fintech positioning provides institutional depth; D/E ratio of 0.23 (Sep 2025) indicates conservative leverage and financial flexibility for capital deployment.
  • Fintech ecosystem expansion (Shopflo acquisition ₹88 Cr, GCash Philippines entry) demonstrates product diversification and geographic reach, supporting long-term revenue growth beyond core payments.
Key Risks:
  • Structural profitability collapse in FY25 (−₹145 Cr net loss, ROE −3.9%, ROCE 0%) indicates severe earnings quality deterioration; OCF remains weak (₹50 Cr in Mar 2025 vs −₹229 Cr prior year), raising doubts on cash-backed earnings recovery despite quarterly margin bounce.
  • IPO lock-in expiry (₹17,372 Cr of shares unlocked) triggering 31% decline from listing price and 10% intraday crash today signals massive seller supply headwind; RSI 25 (oversold) and Delivery % 0.1% (institutional exits dominating) confirm capitulation risk near 52W low of ₹151.15.

AI-generated analysis for informational purposes only — not SEBI-registered investment advice.

See Full AI Analysis — Free FREE →

Latest News

Frequently Asked Questions

What is Pine Labs's current stock price?

Pine Labs shares were last quoted at ₹162.28 (-0.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.

What is the P/E ratio of Pine Labs?

Pine Labs has a price-to-earnings (P/E) ratio of 160.59 and a price-to-book (P/B) ratio of 3.45. The industry P/E is 22.12.

What is the 52-week high and low of Pine Labs?

The 52-week high of Pine Labs is ₹283.70 and the 52-week low is ₹134.75.

What is the market cap of Pine Labs?

The market capitalisation of Pine Labs is about ₹20,398.64 crore.

How did Pine Labs perform in its latest quarterly results?

In the latest quarter (Jun 2026), Pine Labs reported sales of ₹737.00 crore (+19.6%) and net profit of ₹20.00 crore (+300.0%), compared with the same quarter last year.

Is Pine Labs a good stock to buy?

This page is for information and is not investment advice. As per the data shown here, Pine Labs has a 3-year ROE of -3.00%, 3-year profit growth of 36.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.

Which sector does Pine Labs belong to?

Pine Labs belongs to the Finance - Others sector.

Other Finance - Others stocks

All Finance - Others stocks · Browse all stocks A–Z

Go to live page for Pine Labs →